Intrinsic Value of S&P & Nasdaq Contact Us

Agilent Technologies, Inc. A NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
74/100
5/7 Pass
SharesGrow Intrinsic Value
$120.45
+0%
Analyst Price Target
$168.18
+39.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Agilent Technologies, Inc. (A) trades at a trailing P/E of 25.2, forward P/E of 20.2. Trailing earnings yield is 3.97%, forward earnings yield 4.96%. PEG 7.88. Graham Number is $50.04.

Criteria proven by this page:

  • VALUE (58/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 20.2 (down from trailing 25.2) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 7.88 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield 3.97% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 4.96% as earnings recover.
  • Analyst consensus target $168.18 (+39.7% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 74/100 with 5/7 criteria passed.

SharesGrow 7-Criteria Score
74/100
SG Score
View full scorecard →
~
VALUE
58/100
Price-to-Earnings & upside
Proven by this page
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
MOAT
76/100
→ Income
~
GROWTH
45/100
→ Income
INCOME
70/100
→ Income

Valuation Snapshot — A

Valuation Multiples
P/E (TTM)25.2
Forward P/E20.2
PEG Ratio7.88
Forward PEG0.66
P/B Ratio4.71
P/S Ratio4.60
EV/EBITDA18.7
Per Share Data
EPS (TTM)$4.56
Forward EPS (Est.)$5.97
Book Value / Share$24.41
Revenue / Share$24.96
FCF / Share$3.51
Yields & Fair Value
Earnings Yield3.97%
Forward Earnings Yield4.96%
Dividend Yield0.88%
Graham Number$50.04
SharesGrow IV$120.45 (+0%)
Analyst Target$168.18 (+39.7%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 30.9 1.68 3.35 3.38 1.06%
2017 32.0 0.65 4.54 4.90 0.78%
2018 65.8 -1.22 4.55 4.23 0.92%
2019 22.2 0.09 5.01 4.61 0.87%
2020 43.9 -1.39 6.47 5.91 0.70%
2021 39.5 0.56 8.86 7.56 0.49%
2022 33.0 6.25 7.80 6.04 0.60%
2023 24.5 34.23 5.20 4.45 0.87%
2024 29.3 5.62 6.41 5.80 0.73%
2025 31.8 9.41 6.14 5.96 0.68%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $1.40 $4.2B $460M 10.9%
2017 $2.10 $4.47B $684M 15.3%
2018 $0.97 $4.91B $316M 6.4%
2019 $3.37 $5.16B $1.07B 20.7%
2020 $2.30 $5.34B $719M 13.5%
2021 $3.94 $6.32B $1.21B 19.1%
2022 $4.18 $6.85B $1.25B 18.3%
2023 $4.19 $6.83B $1.24B 18.1%
2024 $4.43 $6.51B $1.29B 19.8%
2025 $4.57 $6.95B $1.3B 18.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $5.97 $5.92 – $6.00 $7.4B $7.35B – $7.43B 11
2027 $6.58 $6.47 – $6.71 $7.85B $7.74B – $7.93B 11
2028 $7.30 $6.76 – $7.72 $8.36B $8.35B – $8.38B 5
2029 $8.04 $7.93 – $8.14 $8.81B $8.72B – $8.89B 1
2030 $8.58 $8.47 – $8.69 $9.26B $9.16B – $9.34B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message